Integrating adherence to highly active antiretroviral therapy into children's daily lives: A qualitative study

Pediatrics

Volumn 114, Issue 5, 2004, Pages

  Hammami, Naïma ^a   Nöstlinger, Christiana ^a   Hoerée, Tom ^a   Lefèvre, Pierre ^a   Jonckheer, Tyl ^b   Kolsteren, Patrick ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Pediatric AIDS Referral Center   (Belgium)

Author keywords

Adherence compliance; Antiretroviral treatment; HIV AIDS; Pediatric; Qualitative study

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BELGIUM; CAREGIVER; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DAILY LIFE ACTIVITY; FEMALE; HEALTH CARE COST; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTERVIEW; LABORATORY TEST; MALE; MEDICAL INFORMATION; MEDICAL LITERATURE; MOTIVATION; PATIENT REFERRAL; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SELF REPORT; DRUG SELF ADMINISTRATION; HOME CARE; INTERPERSONAL COMMUNICATION; MOTHER CHILD RELATION; PATIENT COMPLIANCE; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAREGIVERS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HOME NURSING; HUMANS; INFANT; MALE; MOTHER-CHILD RELATIONS; MOTIVATION; PATIENT COMPLIANCE; SELF ADMINISTRATION; TRUTH DISCLOSURE;

EID: 15044353061     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0085     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep. 1998;47:1-43
2. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection: Update of December 14, 2001. Available at: www.hivatis.org
3. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection in children: Italian Register HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190-197
4. Stewart K, Dearmun A. Adherence to health advice amongst young people with chronic illness. J Child Health Care. 2001;5:155-162
5. Paterson D, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infections. Ann Intern Med. 2000;133:21-30
6. Friedland GH, Andrews LA. Adherence to antiretroviral therapy. AIDS Rev. 2001;3:111-120
7. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153
8. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999;18:682-689
9. Cohen J, Reddington C, Jacobs D, et al. School related issues among HIV-infected children. Pediatrics. 1997;100(1). Available at: www.pediatrics.org/cgi/content/full/100/1/e8
10. Byrne M, Honig J, Jurgrau A, et al. Achieving adherence with antiretroviral medications for pediatric HIV disease. AIDS Read. 2002;12:151-164
11. Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research. 3rd ed. London, United Kingdom: Sage; 2000
12. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis J. 2000;30(suppl 2):S171-S176
13. Steele RG, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendation for research. Clin Child Fam Psychol Rev. 2003;6:17-30
14. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13:617-629
15. Katko E, Johnson GM, Fowler SL, Turner RB. Assessment of adherence with medications in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2001;20:1174-1176
16. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109(4). Available at: www.pediatrics.org/cgi/content/full/109/4/e61
17. Pontali E, Feasi M, Toscanini F, et al. Adherence to combination antiretroviral treatment in children. HIV Clin Trials. 2001;2:466-473
18. Donaghy S, Waugh S, Wallace C, et al. Adherence to paediatric antiretroviral therapy. AIDS. 2000;14(suppl 4):S78
19. Albano F, Spagnuolo MI, Berni CR, Guarino A. Adherence to antiretroviral therapy in HIV-infected children in Italy. AIDS Care. 1999;11:711-714
20. Gibb DM, Goodall RL, Giacomet V, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22:56-62
21. Murphy D, Sarr M, Durako S, et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157:249-255
22. Roberts K, Volberding P. Adherence communication: a qualitative analysis of physician-patient dialogue. AIDS. 1999;13:1771-1778
23. Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003;36:514-518
24. Turner B. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis. 2002;185(suppl 2):S143-S151
25. Bartlett J. Addressing the challenge of adherence. J Acquir Immune Defic Syndr. 2002;29(suppl 1):S2-S10
26. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action; 2003. available at: www.who.int/chronic_conditions/adherencereport/en/
27. Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665-1670
28. Matsui DM. Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am. 1997;44:1-14
29. Proctor VE, Tesfa A, Tompkins DC. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS. AIDS Patient Care STDS. 1999;13:535-578
30. Davidson O, Deutsch J, Godfrey D, et al. Draft British HIV Association (BHIVA)/Medical Society for the Study of Veneral Diseases (MSSVD) Guidelines on Provision of Adherence Support to Individuals Receiving Antiretroviral Therapy; 2002. Available at: www.aidsmap.org/about/bhiva/bhiva_adherence.asp
31. Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentration in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-395
32. Bryman A, Burgess RG, eds. Analyzing Qualitative Data. London, United Kingdom: Routledge; 1994
33. Molassiotis A, Nahas-Lopez V, Chung WY, et al. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS. 2002;13:301-310
34. Donovan J, Blake D. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992;34:507-513
35. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111:455-474
36. Fisher JD, Fisher WA, Amico KR. An Information-Motivation-Behavioral Skills Model of Adherence to Highly Active Antiretroviral Therapy. Paper presented at the AIDS Impact: Biopsychological Aspects of HIV Infection 5th International Conference; July 8-11, 2001; Brighton, United Kingdom
37. Fisher JD, Fisher WA. Theoretical approaches to individual-level change in risk behavior. In: Paterson JL, DiClemente R, eds. HIV Prevention Handbook. New York, NY: Kluwer Academic/Plenum Publishers; 2000:3-55
38. Kübler-Ross E. On Death and Dying. New York, NY: Touchstone; 1997
39. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance - a meta-analysis. Med Care. 1998;36:1138-1161